Page 400 - Read Online

Page 10 of 11 Paap et al. Plast Aesthet Res 2020;7:36 I http://dx.doi.org/10.20517/2347-9264.2020.121

DECLARATIONS
Authors’ contributions
Made substantial contributions to the conception and design of the study; performed literature review,
background research, and data analysis; drafted initial version of the work and contributed to revisions;
drafted initial version of Table 1; edited and augmented Table 2; provided administrative support: Paap MK
Made substantial contributions to the conception and design of the study; reviewed and substantially
revised initial and subsequent drafts of manuscript; reviewed and analyzed relevant literature; contributed
additional background research; drafted initial version of Table 2; edited and augmented Table 1: Silkiss RZ

Availability of data and materials
Not applicable.

Financial support and sponsorship
None.

Conflicts of interest
Both authors declared that there are no conflicts of interest.

Ethical approval and consent to participate
Not applicable.

Consent for publication
Not applicable.

Copyright
© The Author(s) 2020.

REFERENCES
1. Farolch-Prats L, Nome-Chamorro C. Facial contouring by using dermal fillers and botulinum toxin A: a practical approach. Aesthetic
Plast Surg 2019;43:793-802.
2. Jones D, Tezel A, Borrell M. In vitro resistance to degradation of hyaluronic acid dermal fillers by ovine testicular hyaluronidase.
Dermatol Surg 2010;36:804-9.
3. Urdiales-Galvez F, Delgado NE, Figueiredo V, Lajo-Plaza JV, Mira M, et al. Treatment of soft tissue filler complications: expert
consensus recommendations. Aesthetic Plast Surg 2018;42:498-510.
4. Cavallini M, Gazzola R, Metalla M, Vaienti L. The role of hyaluronidase in the treatment of complications from hyaluronic acid dermal
fillers. Aesthet Surg J 2013;33:1167-74.
5. Hylenex [Package insert]. San Diego, CA: Halozyme Therapeutics, Inc; 2012.
6. Rao V, Chi S, Woodward J. Reversing facial fillers: interactions between hyaluronidase and commercially available hyaluronic-acid based
fillers. J Drugs Dermatol 2014;13:1053-6.
7. Lambros V. The use of hyaluronidase to reverse the effects of hyaluronic acid filler. Plast Reconstr Surg 2004;114:227.
8. Surek CC, Said SA, Perry JD, Zins JE. Retrobulbar injection for hyaluronic acid gel filler-induced blindness: a review of efficacy and
technique. Aesthetic Plast Surg 2019;43:1034-40.
9. Hirsch RJ, Cohen JL, Carruthers JDA. Successful management of an unusual presentation of impending necrosis following a hyaluronic
acid injection embolus and a proposed algorithm for management of hyaluronidase. Dermatol Surg 2007;33:357-60.
10. Paap MK, Milman T, Ugradar S, Goldberg R, Silkiss RZ. Examining the role of retrobulbar hyaluronidase in reversing filler induced
blindness: a systemic review. Ophthalmic Plast Reconstr Surg 2019;2020;36:231-8.
11. Paap MK, Milman T, Ugradar S, Silkiss RZ. Assessing retrobulbar hyaluronidase as a treatment for filler-induced blindness in a cadaver
model. Plast Reconstr Surg 2019;144:315-20.
12. Sall I, Ferard G. Comparison of the sensitivity of 11 crosslinked hyaluronic acid gels to bovine testis hyaluronidase. Polymer Degradation
and Stability 2007;92:915-9.
13. Gold MH. Use of hyaluronic acid fillers for the treatment of the aging face. Clinical Interventions in Aging 2007;2:369-76.
14. Cavallini M, Papagni M, Trocchi G. Sensitivity of hyaluronic acid fillers to hyaluronidase: an in vitro analysis. J Clin Exp Dermatol Res
2020;11:517.